4.6 Editorial Material

Repurposing dopaminergic drugs for MS - the evidence mounts

Journal

NATURE REVIEWS NEUROLOGY
Volume 12, Issue 4, Pages 191-U17

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrneurol.2016.33

Keywords

-

Ask authors/readers for more resources

A new study has shown that both in patients with multiple sclerosis ( MS) and in healthy controls, dopamine inhibits production of IL-17 and IFN-gamma by peripheral blood mononuclear cells. The finding adds to previous evidence for the potential benefit of dopaminergic drugs in MS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available